Twitxy Saved

Samarpana Chakraborty

@Samarpana10

Postdoctoral Researcher @ Albert Einstein College of Medicine
New York, USA Joined February 2015
208 Following 159 Followers 126 Posts

Latest posts 5

Samarpana Chakraborty @Samarpana10
Excited to share the publication of my postdoctoral project titled “A STAT3 degrader demonstrates efficacy in venetoclax resistant acute myeloid leukemia” in Leukemia.
Deeply grateful to my PI @aditishasMD , colleagues, & mentors @keisuke_ito_lab @Amitvermamds for support.
Aditi Shastri, MD @aditishasMD Feb 18
Stoked to share a new paper #shastrilab titled"A STAT3 degrader demonstrates efficacy in venetoclax resistant AML" in @NaturePortfolio Leukemia. Congrats first author @Samarpana10 , thank you amazing collaborators including @keisuke_ito_lab @KymeraTx
montefioreeinstein.org/news/2026/02/1…
View quoted post on X
Samarpana Chakraborty @Samarpana10
Thrilled to share my postdoctoral work on STAT3 degraders in Venetoclax resistant AML. Grateful to #Shastrilab @aditishasMD for giving me the opportunity to work on this fantastic project. @EinsteinMed @Einstein_SCI

Preprint is now available on bioRxiv (biorxiv.org/content/10.110…)
www.biorxiv.org A STAT3 Degrader Demonstrates Pre-clinical Efficacy in Venetoclax resistant Acute Myeloid Leukemia Acute myeloid leukemia (AML) is an aggressive hematologic malignancy that continues to have poor prognosis despite recent therapeutic advances. Venetoclax (Ven), a BCL2-inhibitor has shown a high...
A new manuscript from #shastrilab just dropped! "A STAT3 Degrader Demonstrates Preclinical Efficacy in Venetoclax Resistant AML". Congratulations to first author @Samarpana10 & a huge thanks to amazing collabs & @KymeraTx @Einstein_SCI @MontefioreNYC biorxiv.org/content/10.110…
View quoted post on X
5 replies 7 reposts 36 likes 3.1K views View on X